in Health

Significant proportion of cancer drugs lack proof of added benefit, finds study

1.1k Views

drug

Credit: CC0 Public Domain

Many cancer drugs approved by the European Medicines Agency (EMA) between 1995 and 2020 lack proof of added benefit, particularly those approved through expedited (“fast track”) pathways, finds a study published by The BMJ.

…

Read the full article


Posted by Editor

Making the Ordinary Extraordinary in Paris

Making the Ordinary Extraordinary in Paris
Water scarcity threatens chipmakers like TSMC and could push prices higher, according to S&P

Water scarcity threatens chipmakers like TSMC and could push prices higher, according to S&P